Assessment Tool Validated to Fill Gaps in COPD Disability Management – Physician’s Weekly
A recent study suggests that the Late-Life Function and Disability Instrument is an effective diagnostic instrument to assess COPD disability and function.
Related Articles
Corticosteroid therapy for treating acute exacerbation of interstitial lung diseases: a systematic review
Introduction Acute exacerbation of interstitial lung disease (AE-ILD) often results in death and poses significant challenges in clinical management. While corticosteroids are frequently employed, the…
Five reasons to attend Sleep and Breathing 2025
As the largest pan-European meeting of its kind, the Sleep and Breathing Conference is a not-to-be-missed event for respiratory professionals specialising in sleep respiratory medicine…
Vanzacaftor–tezacaftor–deutivacaftor for children aged 6–11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trial
Vanzacaftor–tezacaftor–deutivacaftor was safe and well tolerated and maintained FEV1 % predicted from elexacaftor–tezacaftor–ivacaftor baseline with further improved CFTR function. Improvements in CFTR function compared with…
Neoadjuvant Immunotherapy in Locally Advanced Mismatch Repair–Deficient Colon Cancer | NEJM
Mismatch repair–deficient (dMMR) tumors can be found in 10 to 15% of patients with nonmetastatic colon cancer. In these patients, the efficacy of chemotherapy is…
Well Known to Us | NEJM
For children with complex and chronic conditions who are well known to their local medical teams, success sometimes simply looks like becoming well known to…
ERS statement on benign pleural effusions in adults
The incidence of non-malignant pleural effusions far outweighs that of malignant pleural effusions and is estimated to be at least 3-fold higher. These so-called benign…
Pulmonary Artery Catheter Use Post Cardiac Surgery Reduces 1-Year Mortality
Patients who receive pulmonary artery catheters (PACs) after cardiac surgery have significantly reduced risk for 1-year mortality.
Cancer Cachexia and the Brain Stem | NEJM
The author describes the science behind a study of ponsegromab to treat cancer cachexia. Ponsegromab suppresses a pathway in neurons located in specific regions of…
Help Us Build the ATS of Tomorrow
Help us build the American Thoracic Society (ATS) of tomorrow, and the next generation of professionals. Your tax-deductible donation is the cornerstone of a stronger…
Smartphone application-based pulmonary rehabilitation in COPD: a multicentre randomised controlled trial
Background Pulmonary rehabilitation (PR) is an essential element of chronic obstructive pulmonary disease (COPD) management. However, access to conventional face-to-face PR programmes is limited. Methods…